A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
As CEO of Centerline Biomedical, Mr. Rackliffe brings more than 20 years of healthcare experience and executive management, spanning both medical device and pharmaceuticals industries, across both public and private sectors. He has successfully led start-ups, as well as company divisions with over $2 billion in annual revenue.
As a growth catalyst, he has successfully launched more than 25 global life science products focusing on the needs of the patient and those that surround the patient/care environment. In addition, he has led and closed multiple global business development deals to drive synergies and growth. He believes that nothing is achieved without a strong team culture and takes pride in building teams that are both highly diverse and value inclusion.
Mr. Rackliffe received his MBA with high distinction from Joseph M. Katz Graduate School of Business, University of Pittsburgh and a duel major BS from Marquette University.